|
KMID : 0032220120240030295
|
|
Annals of Dermatology
2012 Volume.24 No. 3 p.295 ~ p.305
|
|
|
The Efficacy and Safety of 17α-Estradiol (Ell-Cranell® alpha 0.025%) Solution on Female Pattern Hair Loss: Single Center, Open-Label, Non-Comparative, Phase IV Study
|
|
Kim Jae-Hong
Lee Sung-Yul
Lee Hae-Jin
Yoon Na-Young
Lee Won-Soo
|
|
|
Abstract
|
|
|
Background: There are several commercially available agents to treat female pattern hair loss (FPHL), including minoxidil solution, anti-androgen agents and mineral supplements. However, these treatments are not always satisfactory. We report the results of a clinical trial of 17α-estradiol (Ell-Cranell® alpha 0.025%) solution to Korean female patients with FPHL.
Objective: This study was designed to examine the efficacy and safety of Ell-Cranell® alpha 0.025% solution in Korean female patients with FPHL.
Methods: A total of 53 women, 18 to 55 years old, applied topical Ell-Cranell® alpha 0.025% solution once daily for 8 months. Efficacy was evaluated by the change of hair counts and diameter, subjective assessment, and photographic assessment by investigators.
Results: Hair counts and diameter from baseline to 4 and 8 months after treatment increased in treated patients and these changes were statistically significant (p＜0.0001). 17α-estradiol (Ell-Cranell® alpha 0.025%) solution showed significant improvement by subjective self- assessment and by investigator photographic assessment. Ell-Cranell® alpha 0.025% solution was well tolerated over 8-months period.
Conclusion: This study showed that Ell-Cranell® alpha 0.025% solution is a safe and effective agent for Korean women with FPHL. (Ann Dermatol 24(3) 295∼305, 2012)
|
|
|
KEYWORD
|
|
|
17α-estradiol, Ell-Cranell®, Female pattern hair loss
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
   
|